GeoVax Labs, Inc. (GOVX): Operating Income
-$21.64M
Year ended 2025-12-31
-$20.53M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$21.64M | n/m | 2026-04-15, From 2025-01-01 |
| 2024-12-31 | -$25.14M | n/m | 2026-04-15, From 2024-01-01 |
| 2023-12-31 | -$26.74M | n/m | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | -$14.03M | n/m | 2024-02-29, From 2022-01-01 |
| 2021-12-31 | -$18.75M | n/m | 2023-03-23, From 2021-01-01 |
| 2020-12-31 | -$2.82M | n/m | 2022-03-09, From 2020-01-01 |
| 2019-12-31 | -$2.37M | n/m | 2021-03-23, From 2019-01-01 |
| 2018-12-31 | -$2.56M | n/m | 2020-03-24, From 2018-01-01 |
| 2017-12-31 | -$2.17M | n/m | 2019-03-26, From 2017-01-01 |
| 2016-12-31 | -$3.27M | n/m | 2019-03-26, From 2016-01-01 |
| 2015-12-31 | -$2.69M | n/m | 2018-03-23, From 2015-01-01 |
| 2014-12-31 | -$2.74M | n/m | 2017-03-24, From 2014-01-01 |
| 2013-12-31 | -$2.29M | n/m | 2016-03-16, From 2013-01-01 |
| 2012-12-31 | -$2.14M | n/m | 2015-03-20, From 2012-01-01 |
| 2011-12-31 | -$2.35M | n/m | 2014-03-14, From 2011-01-01 |
| 2010-12-31 | -$2.77M | n/m | 2013-03-18, From 2010-01-01 |
| 2009-12-31 | -$3.32M | n/a | 2012-03-30, From 2009-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | -$21.64M | n/m |
| Cartesian Therapeutics, Inc. (RNAC) | 2025-12-31 | -$143.41M | n/m |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | -$160.36M | n/m |
| Xenetic Biosciences, Inc. (XBIO) | 2025-12-31 | -$2.83M | n/m |
| Korsana Biosciences, Inc. (KRSA) | 2025-12-31 | -$4.97M | n/m |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | -$4.39M | n/m |
| Dianthus Therapeutics, Inc. (DNTH) | 2025-12-31 | -$177.93M | n/m |
| Lipocine Inc. (LPCN) | 2025-12-31 | -$10.37M | n/m |
| Bio Essence Corp (BIOE) | 2025-12-31 | $900.0K | n/m |
Compare GOVX, RNAC, UPB, XBIO side by side · Screen every company in Pharmaceutical Preparations ↗